Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYurttaş, Leyla
dc.contributor.authorKaya, Betül
dc.contributor.authorCankılıç, Meral Yılmaz
dc.contributor.authorLevent, Serkan
dc.date.accessioned2019-10-19T14:44:56Z
dc.date.available2019-10-19T14:44:56Z
dc.date.issued2017
dc.identifier.issn1570-1808
dc.identifier.issn1875-628X
dc.identifier.urihttps://dx.doi.org/10.2174/1570180814666170412121402
dc.identifier.urihttps://hdl.handle.net/11421/13646
dc.descriptionWOS: 000412336400010en_US
dc.description.abstractBackground: In this study, 2-(substituted-sulfanyl)-N, N-dicyclohexylacetamide derivatives (2a-2g) and 2-(dicyclohexylamino)-2-oxoethyl-1-substituted carbodithioate derivatives (2h-2m) were synthesized and screened for their antimicrobial activity. Methods: Newly synthesized compounds were screened against two gram negative bacteria (S. typhimurium and E. coli), three gram positive bacteria (S. aureus, B. cereus and L. monocytogenes), four Candida species, four Aspergillus spp. and three Penicillium spp. Among them (2a-2m), compounds 2i (2-(dicyclohexylamino)-2-oxoethyl-thiomorpholine-4-carbodithioate) and 2k (2( dicyclohexylamino)-2-oxoethyl-4-(4-methoxyphenyl) piperazine-1-carbodithioate) were detected to have higher inhibitory effect than other compounds. Results and Conclusion: Minumum inhibitor concentrations (MICs) of the compounds were determined between the range of 97.5-390 mu g/mL. Additionally, parameters determined that some physicochemical and toxic properties were predicted using computational methods.en_US
dc.language.isoengen_US
dc.publisherBentham Science Publ LTDen_US
dc.relation.isversionof10.2174/1570180814666170412121402en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDithiocarbamateen_US
dc.subjectLipophilicityen_US
dc.subjectAntifungal Activityen_US
dc.subjectAntibacterial Activityen_US
dc.subjectAdmeen_US
dc.subjectAgentsen_US
dc.titleNew Cyclohexylamine-dithiocarbamate Derivatives as Potential Anti-microbial Agentsen_US
dc.typearticleen_US
dc.relation.journalLetters in Drug Design & Discoveryen_US
dc.contributor.departmentAnadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalıen_US
dc.identifier.volume14en_US
dc.identifier.issue11en_US
dc.identifier.startpage1308en_US
dc.identifier.endpage1315en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.contributor.institutionauthorYurttaş, Leyla


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster